Evidence map›Paper›PMID 40840919›Full record

ArticleNucleic acids research2025

Translocations can drive expression changes of multiple genes in regulons covering entire chromosome arms.

Anna Oncins, Roser Zaurin, Houyem Toukabri, Kimberly Quililan, José R Hernández Mora, Magdalena A Karpinska, Erik Wernersson, Alastair Smith, Agostina Bianchi, Leone Albinati and 15 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Anna OncinsCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Roser ZaurinCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Houyem ToukabriCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Kimberly QuililanCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
José R Hernández MoraCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Magdalena A KarpinskaDepartment of Genome Organization and Regulation, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37077, Germany.
Erik WernerssonDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 17165, Sweden.
Alastair SmithMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
Agostina BianchiCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Leone AlbinatiCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Luca CozzutoCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Andrea RiveroCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Chloe GulliverCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Jessica VeltenCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Johanna DenkenaCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
François SerraLife Sciences Department, Barcelona Supercomputing Center, Barcelona 08034, Spain.
Raúl GómezCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Cristina LópezLymphoid Neoplasms Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Sílvia BeàLymphoid Neoplasms Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
Jonas PaulsenDepartment of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.ORCID 0000-0002-7918-5495
Nadia HalidiCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.
Alfonso ValenciaLife Sciences Department, Barcelona Supercomputing Center, Barcelona 08034, Spain.
Magda BienkoDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 17165, Sweden.
A Marieke OudelaarDepartment of Genome Organization and Regulation, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37077, Germany.
Renée BeekmanCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), C. Dr. Aiguader 88, Barcelona 08003, Spain.ORCID 0000-0001-7081-7874

Funding

AEIEMBO 10156EMERALD International PhD Programme 101034290ERCEuropean Union's Horizon Europe Programme 101039265European Union's Horizon Europe Programme 101088408Generalitat de CatalunyaSpanish Ministry of Science and Innovation CEX2020-001049-SSpanish Ministry of Science and Innovation JDC2022-049014-ISpanish Ministry of Science and Innovation MCIN/AEI /10.13039/501100011033Spanish Ministry of Science and Innovation PRE2019-087574Swedish Cancer Research Foundation 22 2240 Pj 01 HSwedish Research Council 2020-02657_3
6 · The paper itself

Abstract

Chromosomal translocations have largely been implicated in tumor development. However, beyond the consequences of aberrant gene expression near the breakpoint, their effects remain underexplored. In this work, we characterize the interplay between translocations, chromatin organization and gene expression using mantle cell lymphoma (MCL) as a model. We show by in vitro genomic engineering and in MCL patient samples that translocations can drive transcriptional changes at entire chromosome arms affecting multiple genes in a regulon-like fashion. Moreover, we demonstrate a clear link between the translocation-induced transcriptional alterations and genome organization, with genes most susceptible to change expression forming pre-existing ultra-long-range interactions spanning 50 megabases. The translocation involves the strong immunoglobulin enhancer into this 3D interaction, allowing the spread of its regulatory potential over the entire affected chromosome arm. Finally, we show that translocation-induced effects mainly represent expression enhancement of genes already active prior to translocation formation, highlighting the importance of the epigenetic state of the cell in which this initial hit occurs. In summary, by studying genome organization principles in the context of translocations, we describe a new principle of gene regulation, showing that strong enhancers can induce substantial gene expression enhancement through ultra-long-range interactions affecting entire chromosome arms, representing an important new mechanism in health and disease.

Indexed as

Gene Expression Regulation, NeoplasticLymphoma, Mantle-CellRegulonTranslocation, GeneticCell Line, TumorChromatinEnhancer Elements, GeneticEpigenesis, GeneticHumansChromatin

Identifiers

PMID40840919
PMCPMC12370299

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.